Kari B. Wisinski
- Oncology top 2%
- Cancer Treatment and Pharmacology 18
- HER2/EGFR in Cancer Research 16
- Cancer Cells and Metastasis 8
- PARP inhibition in cancer therapy 8
- Cancer Research top 5%
- Breast Cancer Treatment Studies 14
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 7
-
- Advanced Breast Cancer Therapies 21
- Cell Biology top 10%
-
- Estrogen and related hormone effects 13
- Co-authors
- Anita TurkWei XuDavid J. BeebeRuth O’ReganMelissa C. SkalaJosé M. AyusoMurtuza RampurwalaWei Huang
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (17 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Kari B. Wisinski
80 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 110
- Oncology 987
- Cancer Research 426
- Molecular Biology 803
- Pulmonary and Respiratory Medicine 340
- Cell Biology 162
Countries citing papers authored by Kari B. Wisinski
This map shows the geographic impact of Kari B. Wisinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari B. Wisinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari B. Wisinski more than expected).
Fields of papers citing papers by Kari B. Wisinski
This network shows the impact of papers produced by Kari B. Wisinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari B. Wisinski. The network helps show where Kari B. Wisinski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kari B. Wisinski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 41 | |
| 9 | 2018 | 20 | |
| 10 | 2018 | 84 | |
| 11 | 2016 | 155 | |
| 12 | 2016 | 27 | |
| 13 | 2016 | 19 | |
| 14 | 2016 | 48 | |
| 15 | 2014 | 40 | |
| 16 | 2014 | 20 | |
| 17 | 2014 | 204 | |
| 18 | 2013 | 17 | |
| 19 | 2011 | 14 | |
| 20 | 2010 | 19 |
About Kari B. Wisinski
Kari B. Wisinski is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (21 papers), Cancer Treatment and Pharmacology (18 papers), HER2/EGFR in Cancer Research (16 papers), Breast Cancer Treatment Studies (14 papers), Estrogen and related hormone effects (13 papers), Cancer Cells and Metastasis (8 papers), PARP inhibition in cancer therapy (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Oncology (987 citations), Cancer Research (426 citations) and Molecular Biology (803 citations). Kari B. Wisinski has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Anita Turk, Wei Xu, David J. Beebe, Ruth O’Regan, Melissa C. Skala, José M. Ayuso, Murtuza Rampurwala, Wei Huang, Menggang Yu and Amyé Tevaarwerk. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.